Skip to main content
. 2012 Jun 14;2012:523842. doi: 10.1155/2012/523842

Table 6.

Ongoing lenalidomide-based regime trials.

Name Phase Age Histology Drugs Status
NCT01415752 II >60 ys Untreated MCL RBV + RL Ongoing and recruiting
NCT01316523 II >18 ys Untreated indolent NHL RL Ongoing and recruiting
NCT00695786 II >18 ys Untreated indolent NHL RL Ongoing and recruiting
FIL R2-B II >18 ys Untreated indolent NHL RBL Ongoing and recruiting

RBV: rituximab, bendamustine, bortezomib; RL: rituximab, lenalidomide; RBL: rituximab, bendamustine, lenalidomide.